Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 65,769,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 799,253
Total Buy Value $0 $0 $0 $26,774,976
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 1,212,833 1,454,179 1,660,039 1,942,739
Total Sell Value $87,684,648 $105,784,257 $115,993,702 $123,872,796
Total People Sold 5 7 8 8
Total Sell Transactions 16 25 47 82
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 155
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Noci Darlene Chief Development Officer   •       –      –    2022-10-14 4 OE $1.08 $4,536 D/D 4,200 4,200     -
   Shair Matthew Director   –       •      –    2022-10-07 4 AS $18.69 $235,825 D/D (12,613) 2,114,692     -
   Shair Matthew Director   –       •      –    2022-10-06 4 AS $19.00 $163,552 D/D (8,608) 2,127,305     -
   Shair Matthew Director   –       •      –    2022-10-05 4 AS $19.22 $151,530 D/D (7,884) 2,135,913     -
   Shair Matthew Director   –       •      –    2022-09-15 4 AS $18.34 $103,621 D/D (5,650) 2,143,797     -
   Noci Darlene Chief Development Officer   •       –      –    2022-09-15 4 AS $18.14 $76,188 D/D (4,200) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-09-15 4 OE $1.08 $4,536 D/D 4,200 4,200     -
   Shair Matthew Director   –       •      –    2022-09-14 4 AS $18.36 $241,452 D/D (13,151) 2,149,447     -
   Noci Darlene Chief Development Officer   •       –      –    2022-08-24 4 AS $17.03 $27,316 D/D (1,604) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-08-24 4 OE $1.08 $1,732 D/D 1,604 1,604     -
   Noci Darlene Chief Development Officer   •       –      –    2022-08-15 4 AS $17.02 $44,184 D/D (2,596) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-08-15 4 OE $1.08 $2,804 D/D 2,596 2,596     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-19 4 AS $17.02 $5,412 D/D (318) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-19 4 OE $1.08 $343 D/D 318 318     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-18 4 AS $17.07 $1,707 D/D (100) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-18 4 OE $1.08 $108 D/D 100 100     -
   Shair Matthew Director   –       •      –    2022-07-15 4 AS $18.29 $36,580 D/D (2,000) 2,162,598     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-15 4 AS $17.21 $65,379 D/D (3,782) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2022-07-15 4 OE $1.08 $4,085 D/D 3,782 3,782     -
   Shair Matthew Director   –       •      –    2022-07-13 4 AS $18.25 $1,825 D/D (100) 2,164,598     -
   Noci Darlene See Remarks   •       –      –    2022-07-07 4 AS $17.61 $295,848 D/D (16,800) 0     -
   Noci Darlene See Remarks   •       –      –    2022-07-07 4 OE $1.08 $18,144 D/D 16,800 16,800     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2022-05-17 4 OE $6.89 $99,995 D/D 14,513 14,513     -
   Noci Darlene See Remarks   •       –      –    2022-02-15 4 AS $17.17 $72,114 D/D (4,200) 0     -
   Noci Darlene See Remarks   •       –      –    2022-02-15 4 OE $1.08 $4,536 D/D 4,200 4,200     -
  155 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us